Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients

Concomitant use of adjuvant tamoxifen (TAM) and radiation therapy (RT) is not widely accepted. We aim to assess whether this treatment is associated with an increased risk of developing subcutaneous fibrosis after conservative or radical surgery in breast cancer patients. We analysed 147 women with...

Descripción completa

Detalles Bibliográficos
Autores principales: Azria, D, Gourgou, S, Sozzi, W J, Zouhair, A, Mirimanoff, R O, Kramar, A, Lemanski, C, Dubois, J B, Romieu, G, Pelegrin, A, Ozsahin, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409893/
https://www.ncbi.nlm.nih.gov/pubmed/15328527
http://dx.doi.org/10.1038/sj.bjc.6602146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409893/
https://www.ncbi.nlm.nih.gov/pubmed/15328527
http://dx.doi.org/10.1038/sj.bjc.6602146

Ejemplares similares